AI-generated summary
The authors studied 30 participants with 124 nails affected by onychomycosis, treated with fractional carbon dioxide laser every two weeks plus terbinafine cream daily for six months. They report a clinical efficacy rate of 58.9% at end of treatment, rising to 68.5% three months later, and found better outcomes in younger patients and thinner nails. Only mild burning was reported as an adverse effect, and the abstract does not include a control group.
- Participants
- 30
- Who or what was studied
- 30 participants with 124 nails with clinically and mycologically diagnosed onychomycosis
- Limits stated in the abstract
- The abstract reports a single-arm design with no control group and does not describe a comparison against other treatments.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.